212 related articles for article (PubMed ID: 23669565)
1. hepaCAM and p-mTOR closely correlate in bladder transitional cell carcinoma and hepaCAM expression inhibits proliferation via an AMPK/mTOR dependent pathway in human bladder cancer cells.
Wang Q; Luo C; Wu X; Du H; Song X; Fan Y
J Urol; 2013 Nov; 190(5):1912-8. PubMed ID: 23669565
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the correlations between interferon-γ in patient serum and HEPACAM in bladder transitional cell carcinoma, and the interferon-γ mechanism inhibiting BIU-87 proliferation.
Xu B; He Y; Wu X; Luo C; Liu A; Zhang J
J Urol; 2012 Oct; 188(4):1346-53. PubMed ID: 22906662
[TBL] [Abstract][Full Text] [Related]
3. [Influence of hepatocyte cell adhesion molecule on gene expression profile of human bladder transitional cell carcinoma cell line].
Wang QJ; Lv CK; Tao J; Du HF; Fan YR; Song XD; Luo CL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):190-8. PubMed ID: 23643009
[TBL] [Abstract][Full Text] [Related]
4. Functional significance of the hepaCAM gene in bladder cancer.
He Y; Wu X; Luo C; Wang L; Lin J
BMC Cancer; 2010 Mar; 10():83. PubMed ID: 20205955
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
6. 5-azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene.
Wang X; Chen E; Yang X; Wang Y; Quan Z; Wu X; Luo C
Oncol Rep; 2016 Mar; 35(3):1375-84. PubMed ID: 26677113
[TBL] [Abstract][Full Text] [Related]
7. The SMAD2/3 pathway is involved in hepaCAM-induced apoptosis by inhibiting the nuclear translocation of SMAD2/3 in bladder cancer cells.
Wang X; Chen E; Tang M; Yang X; Wang Y; Quan Z; Wu X; Luo C
Tumour Biol; 2016 Aug; 37(8):10731-43. PubMed ID: 26873485
[TBL] [Abstract][Full Text] [Related]
8. Ionizing radiation regulates the expression of AMP-activated protein kinase (AMPK) in epithelial cancer cells: modulation of cellular signals regulating cell cycle and survival.
Sanli T; Storozhuk Y; Linher-Melville K; Bristow RG; Laderout K; Viollet B; Wright J; Singh G; Tsakiridis T
Radiother Oncol; 2012 Mar; 102(3):459-65. PubMed ID: 22225791
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
10. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
[TBL] [Abstract][Full Text] [Related]
11. HepaCAM induces G1 phase arrest and promotes c-Myc degradation in human renal cell carcinoma.
Zhang QL; Luo CL; Wu XH; Wang CY; Xu X; Zhang YY; Liu Q; Shen SL
J Cell Biochem; 2011 Oct; 112(10):2910-9. PubMed ID: 21618595
[TBL] [Abstract][Full Text] [Related]
12. G9a Inhibition Induces Autophagic Cell Death via AMPK/mTOR Pathway in Bladder Transitional Cell Carcinoma.
Li F; Zeng J; Gao Y; Guan Z; Ma Z; Shi Q; Du C; Jia J; Xu S; Wang X; Chang L; He D; Guo P
PLoS One; 2015; 10(9):e0138390. PubMed ID: 26397365
[TBL] [Abstract][Full Text] [Related]
13. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-1285 Regulates 17β-Estradiol-Inhibited Immature Boar Sertoli Cell Proliferation via Adenosine Monophosphate-Activated Protein Kinase Activation.
Jiao ZJ; Yi W; Rong YW; Kee JD; Zhong WX
Endocrinology; 2015 Nov; 156(11):4059-70. PubMed ID: 26287402
[TBL] [Abstract][Full Text] [Related]
15. Exon 2 methylation inhibits hepaCAM expression in transitional cell carcinoma of the bladder.
Pan C; Wu X; Luo C; Yang S; Pu J; Wang C; Shen S
Urol Int; 2010; 85(3):347-54. PubMed ID: 20628239
[TBL] [Abstract][Full Text] [Related]
16. Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder.
Sun CH; Chang YH; Pan CC
Histopathology; 2011 Jun; 58(7):1054-63. PubMed ID: 21707707
[TBL] [Abstract][Full Text] [Related]
17. Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line.
Aranha O; Wood DP; Sarkar FH
Clin Cancer Res; 2000 Mar; 6(3):891-900. PubMed ID: 10741713
[TBL] [Abstract][Full Text] [Related]
18. Significance of 4E-binding protein 1 as a therapeutic target for invasive urothelial carcinoma of the bladder.
Nishikawa M; Miyake H; Behnsawy HM; Fujisawa M
Urol Oncol; 2015 Apr; 33(4):166.e9-15. PubMed ID: 25618298
[TBL] [Abstract][Full Text] [Related]
19. Expression of hepaCAM inhibits bladder cancer cell proliferation via a Wnt/β-catenin-dependent pathway in vitro and in vivo.
Du HF; Ou LP; Lv CK; Yang X; Song XD; Fan YR; Wu XH; Luo CL
Cancer Biol Ther; 2015; 16(10):1502-13. PubMed ID: 26192362
[TBL] [Abstract][Full Text] [Related]
20. Renal tumor-derived exosomes inhibit hepaCAM expression of renal carcinoma cells in a p-AKT-dependent manner.
Jiang XL; Zhang Y; Tan B; Luo CL; Wu XH
Neoplasma; 2014; 61(4):416-23. PubMed ID: 24645843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
